We intend to create shareholder value by building a broader-based diagnostic company with products in market segments in which we have significant expertise and know-how.
In doing so, we will address gaps in our current product portfolio as well as key unmet clinical needs (that are identified by our scientific advisors). A particular emphasis will be placed on faster growing POC and MDx products.
Core Values